Mary Doubleday

Title: Mary Doubleday: Innovator in Therapeutic Applications of Squalamine

Introduction

Mary Doubleday is a notable inventor based in Plymouth Meeting, Pennsylvania. She has made significant contributions to the field of pharmaceuticals, particularly through her innovative work on squalamine dilactate. Her research focuses on the therapeutic applications of this compound, which has implications for treating various medical conditions.

Latest Patents

Mary Doubleday holds a patent for "Polymorphic and amorphous salt forms of squalamine dilactate." This invention relates to the selection of squalamine salts, methods of their synthesis, and their therapeutic uses. The patent highlights the advantages of these salts in terms of manufacturing, product stability, and toxicity. Specifically, it addresses various forms of the dilactate salt of squalamine and their utility in inhibiting neovascularization and endothelial cell proliferation.

Career Highlights

Throughout her career, Mary has worked with several companies, including Ohr Pharmaceuticals, Inc. and Enterin, Inc. Her work has been instrumental in advancing the understanding and application of squalamine in medical treatments.

Collaborations

Mary has collaborated with notable professionals in her field, including Eric Chellquist and Charles Gilbert. These partnerships have contributed to her innovative research and the successful development of her patented technologies.

Conclusion

Mary Doubleday's contributions to the field of pharmaceuticals through her patent on squalamine dilactate exemplify her commitment to innovation and therapeutic advancement. Her work continues to influence the medical community and offers promising avenues for future research.